Caring for patients with severe bronchiectasis can be complex.
Partner with us for round-the-clock pulmonology expertise, delivered remotely to support inpatient care teams.

#TeleICU
#PulmonaryCare
#BronchiectasisCare
#HospitalMedicine
#CriticalCareSupport

Living with asthma? 🫁

We spoke with Fernando Holguin, MD, from @cupaccm.bsky.social, about the key do’s and don’ts for managing asthma safely and staying active.

#AsthmaAwareness #PulmonaryCare #Medicine

Airway Stents Market Size, Share, Trends & Forecast 2035 Airway Stents Market growth is projected to reach 7.532 USD billion, at a 6.15% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 to 2035.

Rising respiratory disorders are fueling demand in the Airway Stents Market. 🫁🩺 www.marketresearchfuture.com/reports/airw...
#PulmonaryCare

Redirecting

Wayne State EACPHS highlight how age-related physiologic changes, polypharmacy, and financial barriers impact pulmonary care in older adults.
Proper device selection + inhaler technique + Medicare navigation = better outcomes.
🔗 doi.org/10.1016/j.cg...

#Geriatrics #PulmonaryCare #PharmacyResearch

Pulmonary Embolism Therapeutics Market Size, Growth By 2035 Pulmonary Embolism Therapeutics Market growth is projected to reach USD 2.26 Billion, at a 5.92% CAGR by driving industry, top company analysis, segments research, trends and forecast report 2025 to 2...

🫁 Life-saving innovation! The Pulmonary Embolism Therapeutics Market expands with novel drugs & rapid diagnosis solutions. Details: www.marketresearchfuture.com/reports/pulm... #Cardiology #PulmonaryCare #PharmaResearch

PureTech forms spins out Celea Therapeutics to advance fibrosis therapy Celea Therapeutics' lead candidate is a Phase III-ready dupirfenidone, following strong Phase IIb results in idiopathic pulmonary fibrosis (IPF).

PureTech launches Celea Therapeutics to advance deupirfenidone, a Phase III-ready candidate showing strong results in idiopathic pulmonary fibrosis (IPF).
#News #IPF #LungHealth #MedicalInnovation #Biotech #RespiratoryMedicine #ClinicalTrials #PharmaNews #PulmonaryCare #DrugDevelopment

PureTech forms spins out Celea Therapeutics to advance fibrosis therapy Celea Therapeutics' lead candidate is a Phase III-ready dupirfenidone, following strong Phase IIb results in idiopathic pulmonary fibrosis (IPF).

PureTech launches Celea Therapeutics to advance deupirfenidone, a Phase III-ready candidate showing strong results in idiopathic pulmonary fibrosis (IPF).
#News #IPF #LungHealth #MedicalInnovation #Biotech #RespiratoryMedicine #ClinicalTrials #PharmaNews #PulmonaryCare #DrugDevelopment

Respiratory Inhaler Device Market Anticipated to Reach USD 56.8 Billion, at a Notable 3.59% CAGR by 2032 - Industry Today Respiratory Inhaler Device Market CAGR is expected to be around 3.59% during the forecast period 2025 - 2032

🌬️ Respiratory Inhaler Device Market expected to breathe in $56.8B by 2032 with a 3.59% CAGR 💨

#Inhalers #RespiratoryHealth #PulmonaryCare

industrytoday.co.uk/health_and_s...

Cystic Fibrosis Therapeutics Market Set to Reach USD 19.4 Billion, with a Healthy 9.04% CAGR Till Forecasts 2032 - Industry Today Cystic Fibrosis Cf Therapeutics Market CAGR is expected to be around 9.04% during the forecast period 2025 - 2032

🧬 Cystic Fibrosis Therapeutics Market breathes big—reaching $19.4B by 2032 at 9.04% CAGR 💊

#CysticFibrosis #RareDiseases #PulmonaryCare

industrytoday.co.uk/health_and_s...

August is #NationalImmunizationAwarenessMonth!

Vaccines protect people of all ages from serious respiratory infections and complications.

From flu shots to RSV prevention—let’s spread knowledge, not illness. 💉🫁

#NIAM #LungHealth #VaccinesWork #PulmonaryCare

Valley Fever Market Overview, Global Size, Analysis, Industry Forecast to 2032 Valley Fever Market to Incur Steady Growth By 2032, Global Valley Fever Market Size, Share, Growth, Trends and Industry Analysis by Types of Treatment, Site of Infection, Strategy Profiling | Valley F...

🌵😷 Fungal foe exposed! Climate change and travel raise Valley Fever’s profile—and treatment urgency.
#ValleyFever #FungalInfections #InfectiousDisease #PulmonaryCare

www.marketresearchfuture.com/reports/vall...

Stay informed with The Canadian Journal of Respiratory, Critical Care, and Sleep Medicine — the official journal of the Canadian Thoracic Society!

Explore the latest research and clinical updates today!
#CTS #RespiratoryMedicine #PulmonaryCare #SleepMedicine #CriticalCare #RespiratoryResearch

Obstructive Lung Disease Market Size, Share, Trends 2032 | MRFR Obstructive Lung Disease Market to reach USD 52.16 Billion at a CAGR 5.12% by 2032, Americas is projected to hold the largest share Due to presence of superior research and development base and greate...

Breathing shouldn’t be a battle! Innovations driving better lung function.
#LungDisease #COPD #RespiratoryDevices #PulmonaryCare

www.marketresearchfuture.com/reports/obst...

Japan Nontuberculous Mycobacteria Market Size, Growth Report 2035 Japan Nontuberculous Mycobacteria Market Industry is expected to grow from 374(USD Million) in 2024 to 490 (USD Million) by 2035. The Japan Nontuberculous Mycobacteria Market CAGR (growth rate) is exp...

🧫 Rare yet rising! 🇯🇵 Japan’s NTM Infection Market gains momentum with novel diagnostics & treatment.
👉 www.marketresearchfuture.com/reports/japa...

#NTM #InfectiousDisease #JapanHealthcare #PulmonaryCare

A Data-driven Approach to Selecting Pulmonary and Critical Care Fellows for Interviews

@atscommunity.bsky.social #PulmonaryCare #CriticalCare

www.atsjournals.org/doi/full/10....

Thrilled to be at #ATS2025! 🫁✨

The Medlive team is on the ground connecting with inspiring leaders from our partner @aafanational.bsky.social, sharing powerful insights on patient-centered approaches to #PulmonaryCare.

Read more: bit.ly/4moGRpZ

@atscommunity.bsky.social

When the doctor becomes the patient…

At a Boehringer Ingelheim event tonight at #ATS2025, Dr. Maryluz Fuentes shared her powerful story of being diagnosed with ILD after years of treating it in others.

"I empowered myself. I read as much as I could."

#ILD #PulmonaryCare @amjreviews.bsky.social

Could New COPD Criteria Double Diagnosis Rates? Multidimensional schema incorporating CT imaging and symptoms identifies high-risk patients without traditional airflow obstruction.

Proposed changes to COPD diagnostic criteria may influence how—and how often—patients are identified.
#ATS2025 #PulmonaryCare #MedSky

Connect with Nova Biomedical at @atscommunity.bsky.social 2025 in San Francisco, May 18-20. Visit Booth #1059 to learn how the Stat Profile Prime Plus® blood gas analyzer supports fast, accurate pulmonary & critical care diagnostic results.
#ATS2025 #criticalcare #pulmonarycare #healthcaretechnology

From Tatooine to Hoth, everyone deserves to breathe easy. Celebrating Star Wars Day with a commitment to lung health. #StarWarsDay #PulmonaryCare